Inmagene Biopharmaceuticals Completes Ikena Oncology Merger, Raises $75Million Private Placement
July 28, 2025
The combined company will operate under the name “ImageneBio, Inc.” and will begin trading on Nasdaq under the ticker symbol “IMA” at market open on